Internal Medicine/Pulmonary and Critical Care Medicine

 

Timothy Evans, MD, PhD

Professor of Medicine, UCSF
Director of Intensive Care Units

 

 

 

 

 

 

 


 

  Medical School: University of Rochester
  Residency: University of Rochester, Strong Memorial
  Fellowship: Pulmonary/Critical Care, Univ. of Rochester School of Med., Pulmonary & Critical Division (Clinical Investigator Pathway)
  Board Certified: Internal Medicine
Critical Care Medicine
Pulmonary Medicine
  Awards and Recognition:

Selected as one of Best Doctors of America 2009-2010
UCSF Kaiser Award for Excellence in Teaching, Nominee 2011
Selected as one of Best Doctors of America 2011-2012
Selected as one of Best Doctors of America 2012-2013
Selected as one of Best Doctors of America 2013-2014

UCSF Kaiser Award for Excellence in Teaching, Nominee 2014
  Publications (since 2009):  
   

Jamshidi N, Miller FJ, Mandel J, Evans T, Kuo MD.  Individualized Therapy of HHT Driven by Network Analysis of Metabolomic Profiles. BMC Syst Biol. 2011 Dec 20;5:200. doi: 10.1186/1752-0509-5-200.  PMID: 22185482 [PubMed - indexed for MEDLINE] PMCID: PMC3339509 


Foraker AB, Camus SM, Evans TM, Majeed SR, Chen CY, Taner SB, Corrêa IR, Doxsey SJ, Brodsky FM. Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG. J Cell Biol. 2012 Aug 20; 198(4):591-605. PMID: 22891263. PMCID: PMC3514040


Spano SJ, Reagle Z, Evans T.  Symptomatic Hypotonic Hyponatremia Presenting at High Altitude.  Wilderness Environ Med. 2014 Mar;25(1):69-74. doi: 10.1016/j.wem.2013.09.014. Epub 2014 Jan 8.  PMID: 24411978 [PubMed - in process]


Majeed SR, Vasudevan L, Chen CY, Luo Y, Torres JA, Evans TM, Sharkey A, Foraker AB, Wong NM, Esk C, Freeman TA, Moffett A, Keen JH, Brodsky FM. Clathrin light chains are required for the gyrating-clathrin recycling pathway and thereby promote cell migration. Nat Commun. 2014; 5:3891. PMID: 24852344. PMCID: PMC4050264

  Research:  
   

Intermune PIPIF-012 An open-label extension study of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis 2013-2016

 

Intermune PIPIF-031 A treatment protocol to allow patients in the United States with idiopathic pulmonary fibrosis access to pirfenidone 2014-2016